Supriya Lifescience Schedules Board Meeting for Q2 and H1 FY27 Results
Supriya Lifescience Ltd 路 Intimation 路 06 Nov 2026, 5:30 am
Supriya Lifescience Schedules Board Meeting for Q2 and H1 FY27 Results Supriya Lifescience Limited has scheduled its Board of Directors meeting for 6th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, per the company's Insider Trading Code of Conduct, the trading window for dealing in company securities by designated persons and their immediate relatives has been closed from 1st Oct'26 and will remain shut until 48 hours following the declaration of the financial results on 6th Nov'26.
Original exchange filing (PDF)
More announcements from Supriya Lifescience Ltd
- Earnings Call Transcript is enclosed herewith. 路 13 Nov 2026
- Outcome of the Results Earning Call for Quarter and Half year ended September 30, 2026 is enclosed herewith. 路 07 Nov 2026
- Press Release is enclosed herewith. 路 07 Nov 2026
- Investor Presentation is enclosed for the Results Earnings Call for quarter and half year ended September 30, 2026. 路 06 Nov 2026
- Change In Management - Appointment of Senior Management Personnel of the Company. 路 06 Nov 2026
- Please find enclosed. 路 06 Nov 2026
- Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 06 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held .... 路 06 Nov 2026
